Anthem Blue Cross and Blue Shield launch new health engagement platform
Anthem Blue Cross and Blue Shield in Colorado have announced the launch of Engage, an integrated digital health platform that creates a personalised member experience by connecting health plan and benefits data with individual clinical and claims data, which is pulled from health and wellness apps. Engage will also help members make better cost and quality decisions when accessing care.
Available to in January, some 20 large customers have already signed up for the platform. It will offer employers access to a single web and mobile digital solution which brings all of their employees’ key health and benefits together in one place. It will also provide employees with personalised messaging based on their individual clinical and claims data.
The wellness aspects of Engage will be open to all of a company’s employees, whether they are enrolled in the benefits plan or not, giving employers a way to reach 100% of their employee population.
“Engage is born out of Anthem’s commitment to provide an engaging healthcare experience for everyone while sparking personal action and empowerment,” said Morgan Kendrick, President of Anthem’s National Accounts business segment.
- Bayer and Alibaba Health form new partnership
- Microsoft Korea and Samsung Seoul Hospital sign new MOU
- Spire Healthcare rejects Mediclinic takeover, sales soar
“Rather than contending with a myriad of one-off digital offerings that address only small portions of their health benefits and healthcare or fitness data, Engage brings together an individual’s health and benefits into one location, empowering employees with information and support for better health and better health care decisions.”
Engage is linked with Anthem’s suite of clinical and wellness programs, such as programs for expecting mothers or to help manage chronic conditions. For example, an Anthem nurse will be alerted to connect with a member based on their medical or lifestyle needs and can help members follow their doctors’ plan of care, flagging missed lab tests and providing additional educational resources. It also can give members instant access to telehealth services, saving time and money.
Developed in collaboration with health navigation platform Castlight Heath, Engage includes online guidance and support on health care questions, including assistance to locate after-hours health care and information on out of pocket costs for lab tests, procedures and prescription drugs.
Additionally, it will enable access to information on all of the doctors and hospitals in a member’s network. The digital health platform also connects to fitness trackers and can be used to administer wellness challenges and incentives, helping support a company’s culture of health.
“With Engage, employees have real-time and convenient access to a wide range of personalized tools needed to help them be better healthcare consumers and, ultimately, healthier people,” Kendrick said.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”